K. Kalla, G. Christ, and R. Karnik, Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry), Circulation, vol.113, pp.2398-405, 2006.

J. G. Jollis, M. L. Roettig, and A. O. Aluko, Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction, JAMA, vol.298, pp.2371-80, 2007.

J. G. Jollis, A. Hr, and L. Monk, Expansion of a Regional ST-SegmentElevation Myocardial Infarction System to an Entire State, Circulation, vol.126, pp.189-95, 2012.

E. I. Chazov, L. S. Matveeva, and A. V. Mazaev,

, Ter Arkh, vol.48, pp.8-19, 1976.

M. Huisse, N. Ajzenberg, and L. Feldman, Microparticle-linked tissue factor activity

, Thromb Haemost, vol.101, pp.734-774, 2009.

P. A. Gurbel, V. L. Serebruany, and A. R. Shustov, Coll Cardiol, vol.31, p.146673, 1998.

S. G. Ellis, M. Tendera, and M. A. De-belder, Facilitated PCI in patients with ST-elevation myocardial infarction, N Engl J Med, vol.358, pp.2205-2222, 2008.

K. Dimopoulos, D. Dudek, and F. Piscione, Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-inAMI trial, Int J Cardiol, vol.154, pp.275-81, 2012.

D. Mario, C. Dudek, D. Piscione, and F. , Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial, N Engl J Med, vol.371, pp.2705-2723, 2008.

F. Borgia, S. G. Goodman, and S. Halvorsen, Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis, Eur Heart J, vol.31, pp.2156-69, 2010.

S. P. D'souza, M. A. Mamas, and D. G. Fraser, Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis, Eur Heart J, vol.32, pp.972-82, 2011.

U. Zeymer, H. Arntz, and B. Dirks, Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR), Resuscitation, vol.80, pp.402-408, 2009.

P. G. Steg, E. Bonnefoy, and S. Chabaud, Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial, Circulation, vol.108, pp.2851-2857, 2003.

E. Bonnefoy, P. G. Steg, and F. Boutitie, Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, Eur Heart J, vol.30, pp.1-8, 2009.

N. Danchin, D. Blanchard, and P. G. Steg, Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC, 2000.

, Registry. Circulation, vol.110, pp.1909-1924, 2004.

N. Danchin, E. Durand, and D. Blanchard, Pre-hospital thrombolysis in perspective, Eur Heart J, vol.29, pp.2835-2877, 2008.

H. H. Ting, C. S. Rihal, and B. J. Gersh, 73 White H. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial, Circulation, vol.116, pp.1855-63, 2001.

W. E. Boden, J. Hoekstra, and C. D. Miller, ST-elevation myocardial infarction: the role of adjunctive antiplatelet therapy, Am J Emerg Med, vol.26, pp.212-232, 2008.

F. Van-de-werf, J. Bax, and A. Betriu, Management of acute myocardial infarction in patients presenting with persistent STsegment elevation: the Task force on the management of STsegment elevation acute myocardial infarction of the European Society of Cardiology, Eur Heart J, vol.29, pp.2909-2954, 2008.

G. De-luca, C. M. Gibson, and F. Bellandi, Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis, Heart, vol.94, pp.1548-58, 2008.

N. Von-beckerath, D. Taubert, G. Pogatsa-murray, E. Schömig, A. Kastrati et al., Absorption metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (intracoronary stenting and antithrombotic regimen: choose between 3 high oral doses for immediate clopidogrel effect) trial, Circulation, vol.112, pp.2946-50, 2005.

A. Van't-hof, T. Berg, J. Heestermans, and T. , Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial, Lancet, vol.372, pp.537-583, 2008.

G. Montalescot, M. Borentain, L. Payot, J. P. Collet, and D. Thomas, Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute STsegment elevation myocardial infarction: a meta-analysis, JAMA, vol.292, pp.362-368, 2004.

G. W. Stone, D. Cox, and E. Garcia, Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials, Circulation, vol.104, pp.636-677, 2001.

B. R. Brodie, T. D. Stuckey, C. Hansen, and D. Muncy, Benefit of coronary reperfusion before intervention on outcomes after primary angioplasty for acute myocardial infarction

, Am J Cardiol, vol.85, pp.13-21, 2000.

D. P. Lee, N. A. Herity, and B. L. Hiatt, Adjunctive platelet glycoprotein IIb/IIIa receptor inhibition with tirofiban before primary angioplasty improves angiographic outcomes: results of the tirofiban given in the emergency room before primary angioplasty (TIGER-PA) pilot trial, Circulation, vol.107, pp.1497-501, 2003.

J. Mehilli, A. Kastrati, and S. Schulz, Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial, Circulation, vol.119, pp.1933-1973, 2009.

G. B. Danzi, C. Capuano, M. Sesana, and R. Baglini, Preliminary experience with a high bolus dose of tirofiban during percutaneous coronary intervention, Curr Med Res Opin, vol.19, pp.28-33, 2003.

Z. Huczek, K. J. Filipiak, and J. Kochman, Baseline platelet reactivity in acute myocardial infarction treated with primary angioplasty -influence on myocardial reperfusion, left ventricular performance, and clinical events, Am Heart J, vol.154, pp.62-70, 2007.

T. Bilsel, T. Akbulut, and K. Yesilcimen, Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty, Heart Vessels, vol.21, pp.102-109, 2006.

S. G. Ellis, M. Tendera, and M. A. De-belder, Facilitated PCI in patients with ST-elevation myocardial infarction, N Engl J Med, vol.358, pp.2205-2222, 2008.

C. M. Gibson, A. J. Kirtane, and S. A. Murphy, Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results of the Time to integrilin therapy in acute myocardial infarction (TITAN)-TIMI 34 trial, Am Heart J, vol.152, pp.668-75, 2006.

F. Van-de-werf, J. Bax, A. Betriu, C. Blomstrom-lundqvist, F. Crea et al.,

K. Huber, K. Kastrati, A. Rosengren, A. Steg, P. G. Tubaro et al., Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of

, Eur Heart J, vol.29, pp.2909-2945, 2008.

P. G. Steg, S. K. James, D. Atar, L. P. Badano, C. Blomstromlundqvist et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), vol.33, pp.2569-2619, 2012.

S. Windecker, P. Kolh, F. Alfonso, J. P. Collet, J. Cremer et al., ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Heart J, vol.35, pp.2541-2619, 2014.

K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, B. R. Chaitman et al., the Writing Heart J, vol.33, pp.2551-2567, 2012.

S. L. Chung, M. H. Lei, C. C. Chen, Y. C. Hsu, and C. C. Yang, Characteristics and prognosis in patients with false-positive ST-elevation myocardial infarction in the ED, Am J Emerg Med, vol.31, pp.825-829, 2013.

D. M. Larson, K. M. Menssen, S. W. Sharkey, S. Duval, R. S. Schwartz et al., False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction, JAMA, vol.298, pp.2754-2760, 2007.

D. Hasdai, S. Behar, L. Wallentin, N. Danchin, A. K. Gitt et al., A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS), Eur Heart J, vol.23, pp.1190-1201, 2002.

T. Nfor, L. Kostopoulos, H. Hashim, M. F. Jan, A. Gupta et al., Identifying false-positive ST-elevation myocardial infarction in emergency department patients, angioplasty. Circulation, vol.43, pp.2017-2021, 2005.

E. M. Antman, D. T. Anbe, P. W. Armstrong, E. R. Bates, L. A. Green et al., American College of Cardiology, vol.44, pp.671-719, 2004.

D. S. Pinto, A. J. Kirtane, B. K. Nallamothu, S. A. Murphy, D. J. Cohen et al., Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy, Circulation, vol.114, pp.2019-2025, 2006.

K. Kalla, G. Christ, R. Karnik, R. Malzer, G. Norman et al., Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry), Circulation, vol.113, pp.2398-2405, 2006.

S. D. Kristensen, K. G. Laut, J. Fajadet, Z. Kaifoszova, K. P. et al., European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction, Eur Heart J, vol.35, pp.1957-1970, 2010.

J. M. Mclenachan, H. H. Gray, M. A. De-belder, P. F. Ludman, D. Cunningham et al., Developing primary PCI as a national reperfusion strategy for patients with ST-elevation myocardial infarction: the UK experience, EuroIntervention, vol.8, pp.99-107, 2012.

R. C. Welsh, F. Van-de-werf, C. M. Westerhout, P. Goldstein, A. H. Gershlick et al.,

, Am J Cardiol, vol.114, pp.811-819, 2014.

E. Puymirat, T. Simon, P. G. Steg, F. Schiele, P. Gueret et al., Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction, FAST MI Investigators, vol.308, pp.998-1006, 2000.

G. De-luca, H. Suryapranata, F. Zijlstra, A. W. Van-'t-hof, J. C. Hoorntje et al., ZWOLLE Myocardial Infarction Study Group. Symptom-onset-to

K. A. Fox, P. G. Steg, K. A. Eagle, S. G. Goodman, F. A. Anderson et al.,

A. , Q. A. Gore, J. M. Investigators, and G. , Decline in rates of death and heart failure in acute coronary syndromes, Jama, vol.297, pp.1892-900, 1999.

G. De-luca, H. Suryapranata, J. P. Ottervanger, and E. M. Antman, Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts, Circulation, vol.109, pp.1223-1228, 2004.

E. Puymirat, T. Simon, P. G. Steg, F. Schiele, P. Gueret et al.,

S. Vaur, L. Cambou, J. P. Ferrieres, and J. , Danchin N and for the USIK USIC 2000 and FAST MI Investigators. ST-elevation myocardial infarction, Jama, vol.308, pp.998-1006, 2012.

N. Freemantle, C. J. Young, P. , M. J. Harrison, and J. , beta Blockade after myocardial infarction: systematic review and meta regression analysis, Bmj, vol.318, pp.1730-1737, 1999.

F. M. Sacks, M. A. Pfeffer, L. A. Moye, J. L. Rouleau, J. D. Rutherford et al.,

J. M. Arnold, C. C. Wun, D. Br, and E. Braunwald, New England journal of medicine, vol.335, pp.1001-1010, 1996.

N. Ozasa, T. Morimoto, B. Bao, Y. Furukawa, Y. Nakagawa et al.,

H. Shiomi, J. Tazaki, M. Natsuaki, T. Kimura, and . Credo-kyoto, Beta-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure, Registry Investigators, vol.168, pp.774-783, 2013.

, Task Force on the management of ST-segment elevation acute myocardial infarction of the

E. Society-of-cardiology, P. G. Steg, S. K. James, D. Atar, L. P. Badano et al., ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, European heart journal, vol.33, pp.2569-619, 2012.

S. Bangalore, H. Makani, M. Radford, K. Thakur, B. Toklu et al.,

A. Pj, . Kp, J. Wetterslev, and F. H. Messerli, Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials. The American journal of medicine, vol.127, pp.939-53, 2014.

N. Danchin, J. P. Cambou, G. Hanania, Z. Kadri, N. Genes et al.,

P. Clerson, P. Gueret, and . Investigators, Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry, American heart journal, vol.150, pp.1147-53, 2005.

K. Thygesen, J. S. Alpert, A. S. Jaffe, M. L. Simoons, B. R. Chaitman et al., , vol.126, pp.2020-2055, 2012.

S. Xu, C. Ross, M. A. Raebel, S. Shetterly, C. Blanchette et al., Use of stabilized inverse propensity scores as weights to directly estimate relative risk and its confidence intervals. Value in health : the journal of the International Society for, Pharmacoeconomics and Outcomes Research, vol.13, pp.273-280, 2010.

D. Mukherjee, J. Fang, S. Chetcuti, M. Moscucci, E. Kline-rogers et al.,

C. P. Cannon, E. Braunwald, C. H. Mccabe, D. J. Rader, J. L. Rouleau et al.,

M. A. Pfeffer and . Skene, AM and for the Pravastatin or Atorvastatin Evaluation and Infection TherapyThrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England journal of medicine, vol.350, pp.1495-504, 2004.

L. Wallentin, R. C. Becker, A. Budaj, C. P. Cannon, H. Emanuelsson et al.,

S. James, H. Katus, K. W. Mahaffey, B. M. Scirica, A. Skene et al.,

P. Investigators, Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The New England journal of medicine, vol.361, pp.1045-57, 2009.

S. D. Wiviott, E. Braunwald, C. H. Mccabe, G. Montalescot, W. Ruzyllo et al.,

D. Ardissino, D. Servi, S. Murphy, S. A. Riesmeyer, J. Weerakkody et al., Antman EM and for the TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes

, The New England journal of medicine, vol.357, pp.2001-2016, 2007.

. Fox, for the EURopean trial On reduction of cardiac events with Perindopril in stable artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study), Lancet, vol.362, pp.782-790, 2003.

S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies et al., Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, The New England journal of medicine, vol.342, pp.145-53, 2000.

S. Chatterjee, D. Chaudhuri, R. Vedanthan, V. Fuster, B. Ibanez et al.,

, Early intravenous beta-blockers in patients with acute coronary syndrome: a meta-analysis of randomized trials, International journal of cardiology, vol.168, pp.915-936, 2013.

E. Puymirat, Can beta-blockers be stopped in patients with preserved left ventricular function after acute myocardial infarction? Five-year follow-up of FAST-MI, 2005.

B. Jerbi, M. Sahnoun, L. Abid, S. Krichene, D. Abid et al.,

, kidney disease and myocardial infarction: epidemiological, clinical, therapeutic and prognostic characteristics

, Annales de cardiologie et d'angeiologie, vol.60, pp.127-161, 2011.

T. T. Tsai, U. D. Patel, T. I. Chang, K. F. Kennedy, F. A. Masoudi et al.,

J. C. Messenger, J. S. Rumsfeld, and J. A. Spertus, Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry, JACC Cardiovascular interventions, vol.7, pp.1-9, 2014.

A. College-of-emergency, P. Society-for-cardiovascular, A. Interventions, O. Gara, and P. T. ,

F. G. Kushner, D. D. Ascheim, D. E. Casey, J. Chung, M. K. De-lemos et al.,

. Ak, J. L. Halperin, N. M. Albert, R. G. Brindis, M. A. Creager et al., Cardiology, vol.61, pp.78-140, 2013.

J. S. Birkhead, Thrombolytic treatment for myocardial infarction: an examination of practice in 39

, United Kingdom hospitals. Myocardial Infarction Audit Group. Heart, vol.78, pp.28-33, 1997.

R. Gaelle, B. Magali, and . Serre, Elodie FLOCARD (3), Nicolas EYDOUX

F. Urgence, . Lyon-est, and F. 2. Lyon, Service des Urgences-SMUR

R. Resuval,

/. Urgence and . Smur,

D. Marine, Carlos El KHOURY, issue.1

E. Ali, Groupe de Recherche RESUVal

/. Urgences, C. Smur, and . Hospitalier-de-bourg-en-bresse, Service des Urgences-SMUR

R. Resuval,

/. Urgence, C. Smur, and . Hospitalier-de,

/. Urgences, C. Samu/smur, and . Hospitalier-de-bourg-en-bresse,

B. Magali and . Serre, Elodie FLOCARD (1)

A. Peiretti, Groupe de Recherche RESUVal

R. Resuval and C. Hospitalier-de-vienne, Service des Urgences-SMUR

/. Urgence and . Smur, Les diabétiques présentant un infarctus aigu du myocarde ont-ils vraiment moins mal?

C. Sylvain, Magali BISCHOFF (3)

H. E. Urgences, . Herriot, and F. 2. Lyon, Service des Urgences-SMUR

R. Resuval,

/. Urgence and . Smur, France (malaise, dyspnée, douleur épigastrique) est équivalente dans les deux groupes (25% vs 24%, statistiquement non significatif). La présence d'un diabète n'a pas modifié la prise en charge en terme d'antalgie. 97% des SCA ST+ avec EN > =6 ont bénéficié d'un traitement par un antalgique. Cependant 40% d'entre eux n'ont pas bénéficié d'antalgie par morphinique, qu'ils soient diabétiques ou non. Le taux de décès hospitalier est plus élevé chez les diabétiques que chez les non diabétiques (9% vs 6%, p=0.004) sans lien avec l'EN initiale

, Service d'Accueil des Urgences

R. Guillaume and C. Pascal, Nathalie CHAPELLE, issue.1

, Service d'Accueil des Urgences, Hôpital Edouard Herriot

G. Alexandre, Marie-Cécile ANEZO

, Service d'Accueil des Urgences, Hôpital Edouard Herriot

, Service d'Accueil des Urgences

;. O-capel, ;. Khoury, ;. Flocard, and . Jacob, P Serre, issue.1

L. Samu-smur, P. Sud, and . Bénite,

S. Urgences, L. Ch, and . Hussel, Hôpital Lucien Hussel

H. Urgences and . Lyon-sud,

S. Urgences, C. H. Smur, and . Fleyriat,

E. Bonnefoy-cudraz, ;. Khoury, ;. Mann, ;. Matas, ;. Roussel et al.,

H. Usic and . Cardiologique,

S. Urgences, L. Ch, and . Hussel,

S. Urgences and C. Mutualiste-d'ambérieu,

S. Urgences and N. Ouest,

S. Urgences, C. H. Smur, and . Fleyriat,

M. Grézard, ;. E. Khoury, and ;. P. Serre,

, Service d'Accueil des Urgences, Hôpital Fleyriat

, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

. Reseau-cardiologie-urgence,

, Service d'Accueil des Urgences

, Service d'Accueil des Urgences, Clinique d

, Soins Intensifs de Cardiologie

, SAMU 01, Hôpital Fleyriat

C. E. Khoury, ;. A. Gasser, ;. Serre, and ;. E. Bonnefoy, ) E. Flocard (3) A. Peiretti (4) O. Matas (1)

, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

, SAMU 01, Hôpital Fleyriat

. Reseau-cardiologie-urgence,

, RESeau Cardiologie Urgence

, Soins Intensifs de Cardiologie

G. Ranchon and ;. Serre, ) O. Capel (3) T. Perret (4) N. Eydoux (5) M. Bischoff (6) C. el Khoury

, Service d'Accueil des Urgences

, SAMU 01, Hôpital Fleyriat

, Hôpital Edouard Herriot, vol.69

, RESeau Cardiologie Urgence

. Réseau-cardiologie-urgence, C. Rescue, . Hospitalier-lucien, . Hussel, and F. Vienne, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

, SAMU 01, Hôpital Fleyriat

, Service d'Accueil des Urgences, Centre Hospitalier

, RESeau Cardiologie Urgence

, SAMU, vol.26

, Service d'Accueil des Urgences

, Syndrome coronaire aigu avec sus décalage du segment ST, existe-t-il un paradoxe pour les patients en surpoids?, Centre Hospitalier Lucien Hussel

, Service d'Accueil des Urgences

, SAMU 01, Hôpital Fleyriat

, RESeau Cardiologie Urgence

, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

, Service d'Accueil des Urgences

P. E. Serre-;-c and . Khoury,

, Centre Hospitalier de

, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

. Reseau-cardiologie-urgence,

, Service d'Accueil des Urgences

, SAMU, vol.26

, Service d'Accueil des Urgences

, Soins Intensifs de Cardiologie

, Le délai médian de thrombolyse est de 20 min [15-30] en SMUR vs, vol.46, p.27

C. E. Khoury-;-o and . Capel,

, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel, vol.69

, Service d'Accueil des Urgences

, Centre Hospitalier de

, Soins Intensifs de Cardiologie

P. Serre-;-) and O. Capel,

E. E. Bonnefoy-;-c and . Khoury,

, Centre Hospitalier de

, Hôpital Edouard Herriot, vol.69

. Reseau-cardiologie-urgence,

, RESeau Cardiologie Urgence, RESCUe, VIENNE, France 5. Service d'Accueil des Urgences

, Soins Intensifs de Cardiologie

C. Service-d'accueil-des-urgences, . Hospitalier-lucien, . Hussel, F. Vienne, and . En, avant l'organisation en réseau de la médecine d'urgence autour des centres de cardiologie interventionnelle (CCI), 2004.

, 23 % des patients ont bénéficié d'une angioplastie primaire en, Résultats Nous avons inclus un total de 1699 patients pris en charge en SMUR : 256 en, vol.001, p.0, 2004.

, % des patients ont bénéficié d'une fibrinolyse préhospitalière en 2004, 70 % en 2005, 71 % en, vol.97, p.0, 2004.

M. E. Bischoff-;-c and . Khoury,

P. Serre,

. Reseau-cardiologie-urgence, C. Rescue, . Hospitalier-lucien, . Hussel, and F. 2. Vienne, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

, RESeau Cardiologie Urgence

L. Soins-intensifs-de-cardiologie, . Pradel, and F. Lyon, Pénétrance d'un protocole de prise en charge des Syndromes Coronariens Aigus avec sur-élévation du segment

G. Courtiol-;-) and K. Echahed,

, Centre Hospitalier de la Région Annecienne, SAMU, vol.74

, Service d'Urgences, Centre Hospitalier Lussien-Hussel

, Service de soins intensifs de cardiologie, Hôpital Louis-Pradel

, reperfusion choisi, thrombolyse pré-hospitalière (TPH) ou angioplastie primaire (PPCI), le taux d'administration des médicaments adjuvants, l'orientation des patients lors de la prise en charge initiale

R. De-février, 261 patients sont inclus. Le mode de reperfusion est la TPH dans 21,1 % des cas et la PPCI dans 60,9 % des cas. Le délai médian Premier Contact Médical (PCM) -TPH était de 24 minutes, le délai PCM -PPCI de 97 minutes, 2008.

P. Serre-;-) and Y. Mann, A. PEIRETTI (3), R. ASENCIO (4), M. BOYER
URL : https://hal.archives-ouvertes.fr/hal-00433163

R. Jilwan,

, Centre Hospitalier de

, Service d'Accueil des Urgences, Clinique d

, Service d'Accueil des Urgences

, Service d'Accueil des Urgences

, Service d'Accueil des Urgences

, Service d'Accueil des Urgences, Centre Hospitalier

, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

C. E. Khoury-;-e and . Bonnefoy,

G. Souweine,

, Service d'Accueil des Urgences, Centre Hospitalier Lucien Hussel

, Soins Intensifs de Cardiologie

. Reseau-cardiologie-urgence, C. Rescue, . Hospitalier-lucien, . Hussel, and F. 4. Vienne, Cabinet de médecine générale, 9 rue Gabriel Veyre

, Cabinet de médecine générale, 51 avenue Jules Guesde

, aigu avec sus-décalage du segment ST, sur notre bassin sanitaire. Nous les avons contactés à un mois, six mois et un an après leur sortie d'hôpital. Nous avons recueilli l'ensemble de l'ordonnance puis analysé les taux de traitements appropriés dits « BASI » : Bêta-bloquants, Antiagrégants (aspirine, clopidogrel et/ou prasugrel), Statines et Inhibiteurs de l'enzyme de conversion (IEC). FAST-MI en, 2005.

H. C. Gooding, C. M. Shay, H. Ning, M. W. Gillman, S. E. Chiuve et al.,

F. K. Swirski and M. Nahrendorf, Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure, Science, vol.339, pp.161-166, 2013.

K. Croce and P. Libby, Intertwining of thrombosis and inflammation in atherosclerosis, Curr Opin Hematol, vol.14, pp.55-61, 2007.

L. Drouet, . Bal, and C. Sollier, Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?

R. Virmani, F. D. Kolodgie, A. P. Burke, A. Farb, and S. M. Schwartz,

, Thromb Vasc Biol, vol.20, pp.1262-1275, 2000.

G. Nikolaos, Frangogiannis Pathophysiology of Myocardial Infarction. Compr Physiol, vol.5, pp.1841-1875, 2015.

S. J. Nicholls, C. M. Ballantyne, and P. J. Barter, Effect of two intensive statin regimens on progression of coronary disease, N Engl J Med, vol.365, pp.2078-87, 2011.

P. Libby, The forgotten majority: unfinished business in cardiovascular risk reduction, J Am Coll Cardiol, vol.46, pp.1225-1233, 2005.

G. W. Stone, A. Maehara, and A. J. Lansky, A prospective natural-history study of coronary atherosclerosis, N Engl J Med, vol.364, pp.226-261, 2011.

V. Fuster, B. Stein, J. A. Ambrose, L. Badimon, J. J. Badimon et al., Atherosclerotic plaque rupture and thrombosis. Evolving concepts, Circulation, vol.82, issue.3, pp.47-59, 1990.

J. C. Res, C. De-zwaan, and A. Van-der-laarse, Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase? Circulation, vol.74, pp.1379-89, 1986.

A. C. Maas, R. T. Van-domburg, J. W. Deckers, F. Vermeer, W. J. Remme et al., Sustained benefit at 10-14 years follow-up after thrombolytic therapy in myocardial infarction, Eur Heart J, vol.20, issue.11, pp.819-845, 1999.

E. Boersma, A. C. Maas, J. W. Deckers, and M. L. Simoons, Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour, Lancet, vol.348, issue.9030, pp.771-776, 1996.

, Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2, Lancet, vol.13, issue.2, pp.349-60, 1988.

, The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction, N Engl J Med, vol.329, issue.10, pp.673-82, 1993.

E. J. Topol, E. M. Ohman, P. W. Armstrong, R. Wilcox, A. M. Skene et al., infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial, Circulation, vol.102, issue.15, pp.1761-1766, 2000.

E. J. Topol,

, IIb/IIIa inhibition: the GUSTO V randomised trial, Lancet, vol.357, issue.9272, pp.1905-1919, 2001.

, Assessment of the Safety and Efficacy of a New Thrombolytic Regimen, p.3

. Investigators, Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction, Lancet, vol.358, issue.9282, pp.605-618, 2001.

M. S. Sabatine, C. P. Cannon, C. M. Gibson, J. L. López-sendón, G. Montalescot et al.,

C. F. Mj, K. A. Hill, A. M. Skene, and C. H. Mccabe, Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST segment elevation, N Engl J Med, vol.352, issue.12, pp.1179-89, 2005.

Z. M. Chen, L. X. Jiang, Y. P. Chen, J. X. Xie, H. C. Pan et al., Lancet, vol.366, issue.9497, pp.1607-1628, 2005.

E. M. Antman, D. A. Morrow, C. H. Mccabe, S. A. Murphy, M. Ruda et al., ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction, N Engl J Med, vol.354, issue.14, pp.1477-88, 2006.

S. Yusuf, S. R. Mehta, S. Chrolavicius, R. Afzal, J. Pogue et al., OASIS-6 Trial Group. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial, JAMA, vol.295, issue.13, pp.1519-1549, 2006.

G. De-luca, G. Biondi-zoccai, and P. Marino, Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials, Ann Emerg Med, vol.52, issue.6, pp.665-76, 2008.

L. Belle, D. Savary, N. Dumonteil, M. Villacèque, S. Charpentier et al., Are there good and bad responders to prehospital thrombolysis in the acute phase of myocardial infarction? OPTIMAL study rationale. Arch Mal Coeur Vaiss, vol.99, pp.823-830, 2006.

R. C. Welsh, F. Van-de-werf, C. M. Westerhout, P. Goldstein, A. H. Gershlick et al.,

, Am J Cardiol, vol.114, pp.811-819, 2014.

K. Kalla, G. Christ, R. Karnik, R. Malzer, G. Norman et al., Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry), Circulation, vol.113, pp.2398-2405, 2006.

C. L. Grines, Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty-the strategy of choice, N Engl J Med, vol.335, pp.1313-1316, 1996.

G. W. Stone,

C. L. Grines,

D. A. Cox,

E. Garcia and J. E. Tcheng,

J. J. Griffin and G. Guagliumi,

T. Stuckey,

M. Turco,

J. Carroll and B. D. Rutherford,

. Lansky, Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction, N Engl J Med, vol.346, issue.13, pp.957-66, 2002.

P. G. Steg, E. Bonnefoy, S. Chabaud, F. Lapostolle, P. Dubien et al.,

P. , Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial, Circulation, vol.108, pp.2851-2856, 2003.

. Bonnefoy, Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up, Eur Heart J, vol.30, pp.1598-1606, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00539344

E. C. Keeley, J. A. Boura, and C. L. Grines,

. Esc), P. G. Steg, S. K. James, D. Atar, L. P. Badano et al., ESC Guidelines for the management of acute myocardial infarction in patients presenting with STsegment elevation, European Society of Cardiology, vol.33, pp.2569-2619, 2012.

S. Windecker, P. Kolh, F. Alfonso, J. P. Collet, J. Cremer et al.,

P. Juni, A. P. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser et al., ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Heart J, vol.35, pp.2541-2619, 2014.

S. D. Wiviott, E. Braunwald, C. H. Mccabe, G. Montalescot, W. Ruzyllo et al., TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, vol.357, issue.20, 2001.

L. Wallentin, R. C. Becker, A. Budaj, C. P. Cannon, H. Emanuelsson et al.,

S. James, H. Katus, K. W. Mahaffey, B. M. Scirica, A. Skene et al., Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, vol.361, issue.11, p.1045, 2009.

G. Montalescot, M. D. Ph, W. Arnoud, M. D. Van-'t-hof, . D. Ph et al., for the ATLANTIC Investigators. Prehospital Ticagrelor in ST-Segment Elevation Myocardial Infarction, N Engl J Med, vol.371, pp.1016-1043, 2014.

A. Robert, R. A. Harrington, and G. W. Stone, Platelet Inhibition with Cangrelor in Patients Undergoing PCI, N Engl J Med, vol.361, pp.2318-2347, 2009.

A. M. Bhatt-dl-lincoff, C. M. Gibson, . For, . Champion-platform, and . Investigators, Intravenous Platelet Blockade with Cangrelor during PCI, N Engl J Med, vol.361, pp.2330-2371, 2009.

L. Deepak, M. D. Bhatt, M. P. Gregg, W. Stone, M. D. Kenneth et al.,

M. Gibson, M. D. , P. Steg, M. D. Christian, W. Hamm et al., for the CHAMPION PHOENIX Investigators. Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events, N Engl J Med, vol.368, pp.1303-1313, 2013.

C. P. Cannon and C. M. Gibson,

C. T. Lambrew,

D. Shoultz, D. Levy, W. French, J. M. Gore, and W. D. Weaver,

W. J. Rogers,

G. W. Stone,

C. L. Grines,

D. A. Cox,

E. Garcia and J. E. Tcheng,

J. J. Griffin and G. Guagliumi,

T. Stuckey,

M. Turco,

J. Carroll and B. D. Rutherford,

. Lansky, Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial. infarction, N Engl J Med, vol.346, issue.13, pp.957-66, 2002.

, Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2, Lancet, vol.13, issue.2, pp.349-60, 1988.

M. C. Bahit and C. P. Cannon,

E. M. Antman,

S. A. Murphy and C. M. Gibson,

N. Danchin, L. Vaur, N. Genes, E. S. Angioi, M. Ferrieres et al., Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey, Circulation, vol.99, pp.2639-2644, 1999.

U. Stenestrand, J. Lindback, L. Wallentin, and R. Registry, Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction, JAMA, vol.296, pp.1749-1756, 2006.

G. Tarantini, R. Razzolini, M. Napodano, C. Bilato, and A. Ramondo, Iliceto Heart J, vol.31, pp.676-683, 2010.

E. Puymirat and . Md;,

T. Simon, P. Md, . Steg, . Md;-françois, M. D. Schiele et al.,

K. Khalife, M. Goldstein, M. Md;-simon-cattan, M. Vaur, M. Cambou et al., MD, PhD ; for the USIK USIC 2000 and FAST MI Investigators. Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction, JAMA, vol.308, issue.10, pp.998-1006, 2012.

T. D. Henry, B. T. Unger, S. W. Sharkey, D. L. Lips, W. R. Pedersen et al.,

T. D. Henry, S. W. Sharkey, M. N. Burke, I. J. Chavez, K. J. Graham et al., A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction, Circulation, vol.116, pp.721-728, 2007.

E. Khoury, C. Dubien, P. Bissery, A. Belle, L. Debatty et al., for the AGIR-2 investigators. Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study, Arch Cardiovasc Dis, vol.103, issue.5, pp.285-92, 2010.

D. M. Yellon and D. J. Hausenloy, Myocardial reperfusion injury, N Engl J Med, vol.357, pp.1121-1156, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01608633

Z. Q. Zhao, J. S. Corvera, and M. E. Halkos, Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning, Am J Physiol Heart Circ Physiol, vol.285, pp.579-88, 2003.

F. Thuny, O. Lairez, F. Roubille, N. Mewton, G. Rioufol et al., Post-Conditioning Reduces Infarct Size and Edema in Patients With ST-Segment Elevation Myocardial Infarction, J Am Coll Cardiol, vol.59, pp.2175-81, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02077093

S. Chugh, Early identification of risk factors for sudden cardiac death, Nat Rev Cardiol, vol.7, pp.318-326, 2010.